Makdisi W F, Versland M R
University of Connecticut School of Medicine, Farmington.
Targeted Diagn Ther. 1991;4:151-62.
The use of targeted radiopharmaceuticals in the diagnosis of hepatic structural and functional defects seems to be a promising new field. Two agents, 99mTc-neogalactoalbumin and 99mTc-asialoorosomucoid, have been used with some success in recent studies. More data, however, needs to be obtained on the kinetics of uptake in various disease states. Comparison studies will also need to be done as new agents are developed.
使用靶向放射性药物诊断肝脏结构和功能缺陷似乎是一个很有前景的新领域。在最近的研究中，两种药物，即99m锝-新半乳糖白蛋白和99m锝-去唾液酸糖蛋白，已取得了一定的成功。然而，还需要获得更多关于各种疾病状态下摄取动力学的数据。随着新药物的研发，也需要进行比较研究。
